Notícias · Recifes

Radioligand therapy significantly prolongs progression-free survival in metastatic GEP-NET

Results of the Phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly prolonged progression-free survival in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) compared with targeted therapy

Admin Recifes 15/07/2026 2

Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time

A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune cells to help tumors survive. Researchers say the findings, published in Biofabrication, reveal possible new targets to weaken the cancer's defenses and make

Admin Recifes 15/07/2026 2

New approach could expand CAR T therapy from blood cancers to solid tumors

Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that combining CAR T cell immunotherapy with a targeted radiopharmaceutical significantly improved tumor regression in preclinical models of neuroblastoma, a rare and

Admin Recifes 15/07/2026 2

Could these tiny organs save millions of lives?

If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it become a cycle of educated guesswork: trying one drug combination, waiting, scanning? If the tumor doesn't respond, trying something else. In the meantime,

Admin Recifes 15/07/2026 2

Radiotherapy reprograms immune response in rare skin cancer

A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell lymphoma (CTCL) tumors, according to findings published in the Journal of the American Academy of Dermatology.

Admin Recifes 15/07/2026 1

Largest study yet reveals which cancers have their own microbiomes

For decades, cancer has been thought of as a purely human disease—rogue cells multiplying out of control, with no room for anything else in the picture. But a growing body of research suggests that isn't quite right. Some tumors, it turns out, come with company: communities of ba

Admin Recifes 15/07/2026 2

New drug against metastatic prostate cancer made entirely from human proteins

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published in the journal Signal Transduction and Targeted Thera

Admin Recifes 15/07/2026 2

Team discovers metabolic pathway in cell nucleus that helps cancer progress

A team at Roswell Park Comprehensive Cancer Center has identified a novel metabolic pathway that plays a key role in enabling cancer to progress through gene activation. In a new study published in the journal Nature Communications, the researchers show that shutting down the pat

Admin Recifes 15/07/2026 1

New treatment helps achieve a healthier BMI in people with weight dysregulation after brai

A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England Journal of Medicine. The new drug, setmelanotide, offers h

Admin Recifes 15/07/2026 1

New experimental approach may help overcome drug resistance in deadly brain cancer

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The study shows that an experimental compound called BA-101 can restore the effective

Admin Recifes 15/07/2026 2

Hidden metastases reveal clues to colorectal cancer recurrence

Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict recurrence after treatment. The findings suggest these tiny, often undetectable tumor deposits could serve as a tissue-based marker of residual cancer cells,

Admin Recifes 15/07/2026 2

First-in-human immunotherapy more than doubles progression-free survival in glioblastoma p

Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, underscoring the need for i

Admin Recifes 15/07/2026 1

Acompanhe as Notícias da Recifes